NewtekOne, Inc. (Nasdaq: NEWT) is a financial holding company that provides banking, lending, payments, payroll, and insurance services to small and medium-sized businesses. Its quarterly results are closely watched because the company has been repositioning its business model since acquiring Newtek Bank in early 2023. Management has deliberately shifted from selling the guaranteed portions of SBA 7(a) loans toward holding more of them on its balance sheet, which reduces near-term gain-on-sale income but builds recurring net interest income (NII), the earnings a bank generates from lending. This transition makes third quarter 2026 results a key checkpoint for investors evaluating the durability of NewtekOne's earnings as it matures as a bank holding company. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For the quarter ended September 30, 2026, NewtekOne reported net income of $10.7 million, down from $17.9 million a year earlier. Net income available to common stockholders was $9.6 million, resulting in basic and diluted EPS of $0.34, compared with $0.68 and $0.67, respectively, in the third quarter of 2025. Total revenue of approximately $71.8 million came in below the consensus estimate near $77.5 million, while EPS also missed analyst expectations of roughly $0.45.
The decline largely reflected the company's strategic repositioning. Gain on sale of loans fell to about $32,000 from $9.6 million a year ago, as NewtekOne held more guaranteed portions of SBA 7(a) loans rather than selling them. In contrast, net interest income rose 30% year over year to $18.9 million. The provision for credit losses climbed to $15.4 million from $7.7 million, and the non-GAAP efficiency ratio rose to 58.7% from 56.3%. Management maintained full-year 2026 EPS guidance of $1.70 to $1.80. From what I see, the numbers align with the transition phase management has outlined.
Investor sentiment heading into the report had already been tempered by NewtekOne's August 2026 guidance revision, when management lowered its 2026 EPS outlook to $1.70–$1.80 from a prior range of $2.15–$2.55. The third quarter miss on both revenue and EPS, driven by reduced loan-sale gains and a higher credit loss provision, reinforced concerns about the near-term earnings impact of holding more loans. At the same time, the rapid growth in net interest income and the doubling of deposits were viewed as early validation of the company's shift toward recurring, deposit-funded income. The mixed picture likely kept the focus on management's execution and commentary around the sustainability of the strategy.
Following the third quarter 2026 results, investors will be watching whether net interest income continues to expand as a share of total revenue. Management has said it expects NII to represent 30% or more of total revenue in the second half of 2026 through 2027, up from 22% in the first half of the year. Progress toward that target will be a central measure of whether the strategy is working. I’m watching this closely as a potential signal of longer-term stability.
Credit quality also remains a priority. The provision for credit losses increased meaningfully, and management has noted that the bank's loan portfolio is still seasoning. Any stabilization or deterioration in nonperforming loans and the allowance for credit losses will be closely scrutinized.
Finally, deposit growth is a key advantage to monitor. Total deposits surpassed $2.5 billion, more than double the prior-year level, and NewtekOne has indicated it is exploring strategic options, including licensing its lending and deposit-gathering platforms. How management balances growth, credit costs, and the timing of any strategic moves will shape the outlook for the coming quarters.
In my analysis, I find Tickeron’s AI Screener helpful for quickly filtering stocks by fundamentals, patterns, and performance metrics. It lets me compare names like NewtekOne against peers without spending hours on manual checks, which keeps the focus on the bigger picture of strategy execution and earnings trends.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where NEWT declined for three days, in 215 of 278 cases, the price declined further within the following month. The odds of a continued downward trend are 77%.
The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NEWT as a result. In 70 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
The Moving Average Convergence Divergence Histogram (MACD) for NEWT turned negative on November 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 31 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
The Aroon Indicator for NEWT entered a downward trend on November 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where NEWT advanced for three days, in 213 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
NEWT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.846) is normal, around the industry mean (1.265). P/E Ratio (4.798) is within average values for comparable stocks, (13.523). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.194). Dividend Yield (0.071) settles around the average of (0.036) among similar stocks. NEWT's P/S Ratio (1.216) is slightly lower than the industry average of (3.751).
The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 36 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. NEWT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEWT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 59, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of financial services to small and medium sized businesses
Industry RegionalBanks